scholarly journals Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis

2020 ◽  
Vol 140 (7) ◽  
pp. 1451-1455.e13 ◽  
Author(s):  
Silke Frey ◽  
Heinrich Sticht ◽  
Dagmar Wilsmann-Theis ◽  
Anne Gerschütz ◽  
Katharina Wolf ◽  
...  
2020 ◽  
Author(s):  
Marta Vergnano ◽  
Katarzyna Grys ◽  
Natashia Benzian-Olsson ◽  
Satveer K Mahil ◽  
Charlotte Chaloner ◽  
...  

AbstractThe identification of disease alleles underlying human autoinflammatory diseases can provide important insights into the mechanisms that maintain neutrophil homeostasis. Here, we focused on generalized pustular psoriasis (GPP), a potentially life-threatening disorder presenting with cutaneous and systemic neutrophilia. Following the whole exome sequencing of 19 unrelated cases, we identified one affected individual harbouring a homozygous splice-site mutation (c.2031-2A>C) in MPO. The same homozygous change was subsequently identified in a further subject suffering from acral pustular psoriasis, a disease phenotypically related to GPP.MPO encodes myeloperoxidase, an essential component of neutrophil azurophil granules. Of interest, the c.2031-2A>C allele was previously described as a genetic determinant of myeloperoxidase deficiency (MPOD), a condition which can causes recurrent infections. Here, a systematic literature review identified four individuals suffering from MPOD and pustular skin disease, further strengthening the link between MPO and pustular inflammation.A subsequent analysis of the UK Biobank cohort demonstrated that the c.2031-2A>C allele was associated with increased neutrophil abundance in the general population (P=5.1×10−6). The same applied to three further MPOD mutations for which genotype data was available, with two alleles generating p-values <10−10. Finally, treatment of healthy neutrophils with an MPO inhibitor reduced cell apoptosis, highlighting a mechanism whereby MPO mutations affect granulocyte numbers.These findings identify MPO mutations as genetic determinants of pustular skin disease and neutrophil abundance. Given the recent interest in the development of MPO antagonists for the treatment of neurodegenerative disease, our results also suggest that the pro-inflammatory effects of these agents should be closely monitored.


2021 ◽  
Vol 22 (16) ◽  
pp. 9048
Author(s):  
Dominik Samotij ◽  
Justyna Szczęch ◽  
Adam Reich

Generalized pustular psoriasis (GPP) is a severe, relapsing, immune-mediated disease characterized by the presence of multiple sterile pustules all over the body. The exact pathomechanisms behind GPP remain elusive, although increased interest in the genetic basis and immunological disturbances have provided some revealing insights into the underlying signaling pathways and their mutual interaction. The genetic background of GPP has been thoroughly investigated over the past few years. The conducted studies have identified genetic variants that predispose to pustular forms of psoriasis. The loss-of-function mutation of the interleukin 36 receptor antagonist gene, along with rare gain-of-function mutations in the gene that encodes the keratinocyte signaling molecule (CARD14), are examples of the uncovered abnormalities. Interleukin 36 (IL-36), along with neutrophils, is now considered a central cytokine in GPP pathogenesis, with IL-36 signaling providing a link between innate and adaptive immune responses. More recently, a new concept of inflammation, caused by a predominantly genetically determined abnormal activation of innate immune response and leading to inflammatory keratinization, has arisen. GPP is currently considered a representative of this novel group of skin conditions, called autoinflammatory keratinization diseases. As no therapeutic agents have been approved for GPP to date in the United States and Europe, the novel anti-IL-36R antibodies are particularly promising and may revolutionize management of the disease.


1979 ◽  
Vol 115 (10) ◽  
pp. 1215-1216 ◽  
Author(s):  
F. R. Murphy

1999 ◽  
Vol 61 (2) ◽  
pp. 144-147
Author(s):  
Miyako KUDO ◽  
Yoshihiro UMEBAYASHI ◽  
Tomoe KOTSUJI ◽  
Fujio OTSUKA

2013 ◽  
Vol 75 (6) ◽  
pp. 504-507
Author(s):  
Reiko TSUTSUMI ◽  
Koji ADACHI ◽  
Yuichi YOSHIDA ◽  
Osamu YAMAMOTO

2001 ◽  
Vol 63 (3) ◽  
pp. 248-251 ◽  
Author(s):  
Tomomi NAKATANI ◽  
Minoru TAKATA ◽  
Shigeru KAWARA ◽  
Kiyoshi UCHIDA

Sign in / Sign up

Export Citation Format

Share Document